Assyro AI

FDA Orange Book · active-ingredient family

Fosinopril sodium; hydrochlorothiazide

Fosinopril sodium; hydrochlorothiazide is approved as 1 brand and 9 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:MONOPRIL-HCT · NDA 020286

1

Brand (NDA)

9

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
MONOPRIL-HCTRLD×2BRISTOL MYERS SQUIBBNDA 020286Nov 30, 1994

Generic (ANDA) products (9)

ProductApplicantApplicationTEApproved
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE×2CHARTWELL RXANDA 079025Sep 17, 2010
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE×2AUROBINDO PHARMAANDA 079245ABJul 09, 2009
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE×2INVAGEN PHARMSANDA 090228ABJul 09, 2009
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE×2MYLANANDA 077705Aug 14, 2006
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE×2TEVAANDA 076945Jul 05, 2006
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE×2SANDOZANDA 076961ABSep 28, 2005
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE×2ANI PHARMSANDA 077144Aug 16, 2005
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE×2SUN PHARM INDS LTDANDA 076739Dec 17, 2004
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE×2ANI PHARMSANDA 076608Dec 03, 2004

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Fosinopril sodium; hydrochlorothiazide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.